Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Therapy
Docetaxel-Vinorelbine Combination Successful in Metastatic Breast Cancer Patients
March 31st, 2000
Patients with metastatic breast cancer who have not responded to anthracyclines may improve when given a docetaxel-vinorelbine combination, according to a recent study. To assess the toxicity and response rate of this drug combination on patients with advanced breast cancer, R. Rodriguez and colleagues conducted a study using 96 such patients with a median age of 55 years. The primary metastatic locations in these patients were the liver (46%) and lung (42%), and almost half of the patients had more than one metastatic site. All patients had previously received an anthracycline-containing treatment. Every 21 days, treatment consisted of 75...
Source: Drug Week (2000-03-31)
|
